IBOGF
Price:
$0.007
Market Cap:
$2.94M
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
Industry
Biotechnology
IPO Date
2022-03-01
Stock Exchange
OTC
Ticker
IBOGF
According to Universal Ibogaine Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.70. This represents a change of -51.45% compared to the average of -1.44 of the last 4 quarters.
The mean historical PE Ratio of Universal Ibogaine Inc. over the last ten years is -7.17. The current -0.70 PE Ratio has changed 875.64% with respect to the historical average. Over the past ten years (40 quarters), IBOGF's PE Ratio was at its highest in in the July 2022 quarter at -0.25. The PE Ratio was at its lowest in in the September 2018 quarter at -25.42.
Average
-7.17
Median
-4.71
Minimum
-17.00
Maximum
0
Discovering the peaks and valleys of Universal Ibogaine Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 300.00%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -17.00
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.62 | -88.05% |
| 2021 | -5.18 | -67.63% |
| 2020 | -16.00 | -5.88% |
| 2019 | -17.00 | 300.00% |
| 2018 | -4.25 | -Infinity% |
The current PE Ratio of Universal Ibogaine Inc. (IBOGF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.27
5-year avg
-8.61
10-year avg
-7.17
Universal Ibogaine Inc.’s PE Ratio is greater than Algernon Pharmaceuticals Inc. (-1.32), less than ReNeuron Group plc (-0.01), less than Health Sciences Group, Inc. (-0.00), less than Ayala Pharmaceuticals, Inc. (-0.01), greater than Appili Therapeutics Inc. (-1.32), greater than Restart Life Sciences Corp. (-2.72), less than Galera Therapeutics, Inc. (-0.19), greater than VG Life Sciences Inc. (-3.15), greater than America Great Health (-1.95), greater than Genix Pharmaceuticals Corporation (-28.18),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.32 | $1.92M | |
| -0.01 | $62.89K | |
| -0.00 | $187.09K | |
| -0.01 | $4.41M | |
| -1.32 | $1.82M | |
| -2.72 | $2.27M | |
| -0.19 | $1.89M | |
| -3.15 | $2.11M | |
| -1.95 | $2.12M | |
| -28.18 | $1.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Universal Ibogaine Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Universal Ibogaine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Universal Ibogaine Inc.'s PE Ratio?
How is the PE Ratio calculated for Universal Ibogaine Inc. (IBOGF)?
What is the highest PE Ratio for Universal Ibogaine Inc. (IBOGF)?
What is the 3-year average PE Ratio for Universal Ibogaine Inc. (IBOGF)?
What is the 5-year average PE Ratio for Universal Ibogaine Inc. (IBOGF)?
How does the current PE Ratio for Universal Ibogaine Inc. (IBOGF) compare to its historical average?